SPRINKLR INC-A (CXM)

US85208T1079 - Common Stock

9.225  +0.07 (+0.82%)

Fundamental Rating

5

CXM gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 278 industry peers in the Software industry. Both the profitability and the financial health of CXM get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, CXM is valued expensive at the moment.



5

1. Profitability

1.1 Basic Checks

CXM had positive earnings in the past year.
CXM had a positive operating cash flow in the past year.
CXM had negative earnings in 4 of the past 5 years.
Of the past 5 years CXM 4 years had a positive operating cash flow.

1.2 Ratios

CXM's Return On Assets of 5.14% is fine compared to the rest of the industry. CXM outperforms 76.98% of its industry peers.
Looking at the Return On Equity, with a value of 10.79%, CXM belongs to the top of the industry, outperforming 80.58% of the companies in the same industry.
CXM has a better Return On Invested Capital (6.65%) than 80.58% of its industry peers.
Industry RankSector Rank
ROA 5.14%
ROE 10.79%
ROIC 6.65%
ROA(3y)-4.45%
ROA(5y)-6.93%
ROE(3y)-8.06%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 6.54%, CXM is in the better half of the industry, outperforming 73.02% of the companies in the same industry.
The Operating Margin of CXM (5.31%) is better than 71.94% of its industry peers.
The Gross Margin of CXM (74.26%) is better than 64.03% of its industry peers.
CXM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.31%
PM (TTM) 6.54%
GM 74.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.33%
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CXM is destroying value.
The number of shares outstanding for CXM has been increased compared to 1 year ago.
CXM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 2.93 indicates that CXM is not a great score, but indicates only limited risk for bankruptcy at the moment.
CXM's Altman-Z score of 2.93 is in line compared to the rest of the industry. CXM outperforms 51.08% of its industry peers.
There is no outstanding debt for CXM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.93
ROIC/WACC0.57
WACC11.72%

2.3 Liquidity

CXM has a Current Ratio of 1.61. This is a normal value and indicates that CXM is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.61, CXM perfoms like the industry average, outperforming 48.92% of the companies in the same industry.
A Quick Ratio of 1.61 indicates that CXM should not have too much problems paying its short term obligations.
CXM has a Quick ratio (1.61) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 1.61

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 18.75% over the past year.
Looking at the last year, CXM shows a quite strong growth in Revenue. The Revenue has grown by 18.47% in the last year.
Measured over the past years, CXM shows a very strong growth in Revenue. The Revenue has been growing by 23.70% on average per year.
EPS 1Y (TTM)18.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.09%
Revenue 1Y (TTM)18.47%
Revenue growth 3Y23.7%
Revenue growth 5YN/A
Sales Q2Q%7.71%

3.2 Future

CXM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.85% yearly.
Based on estimates for the next years, CXM will show a quite strong growth in Revenue. The Revenue will grow by 8.38% on average per year.
EPS Next Y-14.28%
EPS Next 2Y4.24%
EPS Next 3Y5.71%
EPS Next 5Y8.85%
Revenue Next Year8.24%
Revenue Next 2Y6.26%
Revenue Next 3Y6.36%
Revenue Next 5Y8.38%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 24.28 indicates a rather expensive valuation of CXM.
Compared to the rest of the industry, the Price/Earnings ratio of CXM indicates a somewhat cheap valuation: CXM is cheaper than 79.14% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.42. CXM is around the same levels.
A Price/Forward Earnings ratio of 21.77 indicates a rather expensive valuation of CXM.
Based on the Price/Forward Earnings ratio, CXM is valued a bit cheaper than the industry average as 78.06% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.56, CXM is valued at the same level.
Industry RankSector Rank
PE 24.28
Fwd PE 21.77

4.2 Price Multiples

CXM's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CXM is cheaper than 76.98% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CXM is valued a bit cheaper than the industry average as 76.98% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 29.02
EV/EBITDA 25.82

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.24%
EPS Next 3Y5.71%

0

5. Dividend

5.1 Amount

CXM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SPRINKLR INC-A

NYSE:CXM (12/20/2024, 11:56:49 AM)

9.225

+0.07 (+0.82%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-04 2024-12-04/amc
Earnings (Next)N/A N/A
Inst Owners50.36%
Inst Owner Change-4.15%
Ins Owners5.28%
Ins Owner Change26.7%
Market Cap2.35B
Analysts68.89
Price Target9.75 (5.69%)
Short Float %9%
Short Ratio3.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.8%
Min EPS beat(2)-14.78%
Max EPS beat(2)24.38%
EPS beat(4)3
Avg EPS beat(4)29.22%
Min EPS beat(4)-14.78%
Max EPS beat(4)59.09%
EPS beat(8)7
Avg EPS beat(8)140.27%
EPS beat(12)11
Avg EPS beat(12)105.89%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.1%
Min Revenue beat(2)-0.18%
Max Revenue beat(2)0.39%
Revenue beat(4)3
Avg Revenue beat(4)1.09%
Min Revenue beat(4)-0.18%
Max Revenue beat(4)2.25%
Revenue beat(8)6
Avg Revenue beat(8)1.03%
Revenue beat(12)10
Avg Revenue beat(12)1.53%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.88%
PT rev (3m)-18.95%
EPS NQ rev (1m)-1.93%
EPS NQ rev (3m)-33.59%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.48%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.27%
Valuation
Industry RankSector Rank
PE 24.28
Fwd PE 21.77
P/S 3.03
P/FCF 29.02
P/OCF 23.15
P/B 5
P/tB 5.6
EV/EBITDA 25.82
EPS(TTM)0.38
EY4.12%
EPS(NY)0.42
Fwd EY4.59%
FCF(TTM)0.32
FCFY3.45%
OCF(TTM)0.4
OCFY4.32%
SpS3.04
BVpS1.84
TBVpS1.65
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.14%
ROE 10.79%
ROCE 7.83%
ROIC 6.65%
ROICexc 64.34%
ROICexgc 818.65%
OM 5.31%
PM (TTM) 6.54%
GM 74.26%
FCFM 10.45%
ROA(3y)-4.45%
ROA(5y)-6.93%
ROE(3y)-8.06%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.33%
GM growth 5YN/A
F-Score7
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 118.72%
Cap/Sales 2.65%
Interest Coverage 250
Cash Conversion 173.78%
Profit Quality 159.88%
Current Ratio 1.61
Quick Ratio 1.61
Altman-Z 2.93
F-Score7
WACC11.72%
ROIC/WACC0.57
Cap/Depr(3y)140.63%
Cap/Depr(5y)130.55%
Cap/Sales(3y)2.65%
Cap/Sales(5y)2.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.09%
EPS Next Y-14.28%
EPS Next 2Y4.24%
EPS Next 3Y5.71%
EPS Next 5Y8.85%
Revenue 1Y (TTM)18.47%
Revenue growth 3Y23.7%
Revenue growth 5YN/A
Sales Q2Q%7.71%
Revenue Next Year8.24%
Revenue Next 2Y6.26%
Revenue Next 3Y6.36%
Revenue Next 5Y8.38%
EBIT growth 1Y1101.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year25.92%
EBIT Next 3Y19.48%
EBIT Next 5Y22.39%
FCF growth 1Y404.84%
FCF growth 3Y294.97%
FCF growth 5YN/A
OCF growth 1Y874.32%
OCF growth 3Y113.83%
OCF growth 5YN/A